Replies to post #277363 on Elite Pharmaceuticals Inc (ELTP)

[lasers]

$ELTP complaint on Pfizer as Pfizer has not yet launched their FDA approved Oxycodone/Naltrexone ADF TROXYCA® ER which was approved Aug 2016

He pointed to drugmakers’ abuse of REMS programs, which can block manufacturers from obtaining the product samples necessary for developing generics, as well as tactics that otherwise frustrate the process following the end of patent exclusivity.